Benzenesulfonamide inhibitors of phosphodiesterase-IV for treating inflammation and TNF associated diseases

A method of inhibiting PDE-IV or TNF comprising contacting a cell with a compound of the formula shown. The pharmaceutical composition is suitable for the treatment of inflammatory or autoimmune diseases. Wherein; R1 and R2 represents C1-4alkyl or C3-10cycloalkyl; R3 and R4 independently represents...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MENETSKI, JOSEPH PETER, CONNOR, DAVID THOMAS
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MENETSKI, JOSEPH PETER
CONNOR, DAVID THOMAS
description A method of inhibiting PDE-IV or TNF comprising contacting a cell with a compound of the formula shown. The pharmaceutical composition is suitable for the treatment of inflammatory or autoimmune diseases. Wherein; R1 and R2 represents C1-4alkyl or C3-10cycloalkyl; R3 and R4 independently represents C1-4alkyl, cycloalkyl, C2-4alkylenes having one double bond, (CH2)nCO(CH2)mCH3, (CH2)pCN, (CH2)pCO2Me, or taken together with nitrogen atom to which they are attached, form a 3-to 10-membered ring; n and m are 0-3; p is 1 to 3.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NZ502965A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NZ502965A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NZ502965A3</originalsourceid><addsrcrecordid>eNqFjrEKwkAQRNNYiPoLsj8QECWCZRSDNqmChU1Yc3tmMdkNt2fj13uFvcXwGHgDM89eR5IPCdl78Co4siNg6fnBUYOBeph6tRTHZJECGuXXG3gNEANhZHkm3w84jqmoAIqDpq4AzbRjjOTAsVHa2TKbeRyMVj8usnV1bk6XnCZtySbs0pHY1vdisz3si3L3V_gC5o1BJA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Benzenesulfonamide inhibitors of phosphodiesterase-IV for treating inflammation and TNF associated diseases</title><source>esp@cenet</source><creator>MENETSKI, JOSEPH PETER ; CONNOR, DAVID THOMAS</creator><creatorcontrib>MENETSKI, JOSEPH PETER ; CONNOR, DAVID THOMAS</creatorcontrib><description>A method of inhibiting PDE-IV or TNF comprising contacting a cell with a compound of the formula shown. The pharmaceutical composition is suitable for the treatment of inflammatory or autoimmune diseases. Wherein; R1 and R2 represents C1-4alkyl or C3-10cycloalkyl; R3 and R4 independently represents C1-4alkyl, cycloalkyl, C2-4alkylenes having one double bond, (CH2)nCO(CH2)mCH3, (CH2)pCN, (CH2)pCO2Me, or taken together with nitrogen atom to which they are attached, form a 3-to 10-membered ring; n and m are 0-3; p is 1 to 3.</description><edition>7</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20020301&amp;DB=EPODOC&amp;CC=NZ&amp;NR=502965A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20020301&amp;DB=EPODOC&amp;CC=NZ&amp;NR=502965A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MENETSKI, JOSEPH PETER</creatorcontrib><creatorcontrib>CONNOR, DAVID THOMAS</creatorcontrib><title>Benzenesulfonamide inhibitors of phosphodiesterase-IV for treating inflammation and TNF associated diseases</title><description>A method of inhibiting PDE-IV or TNF comprising contacting a cell with a compound of the formula shown. The pharmaceutical composition is suitable for the treatment of inflammatory or autoimmune diseases. Wherein; R1 and R2 represents C1-4alkyl or C3-10cycloalkyl; R3 and R4 independently represents C1-4alkyl, cycloalkyl, C2-4alkylenes having one double bond, (CH2)nCO(CH2)mCH3, (CH2)pCN, (CH2)pCO2Me, or taken together with nitrogen atom to which they are attached, form a 3-to 10-membered ring; n and m are 0-3; p is 1 to 3.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFjrEKwkAQRNNYiPoLsj8QECWCZRSDNqmChU1Yc3tmMdkNt2fj13uFvcXwGHgDM89eR5IPCdl78Co4siNg6fnBUYOBeph6tRTHZJECGuXXG3gNEANhZHkm3w84jqmoAIqDpq4AzbRjjOTAsVHa2TKbeRyMVj8usnV1bk6XnCZtySbs0pHY1vdisz3si3L3V_gC5o1BJA</recordid><startdate>20020301</startdate><enddate>20020301</enddate><creator>MENETSKI, JOSEPH PETER</creator><creator>CONNOR, DAVID THOMAS</creator><scope>EVB</scope></search><sort><creationdate>20020301</creationdate><title>Benzenesulfonamide inhibitors of phosphodiesterase-IV for treating inflammation and TNF associated diseases</title><author>MENETSKI, JOSEPH PETER ; CONNOR, DAVID THOMAS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NZ502965A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2002</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MENETSKI, JOSEPH PETER</creatorcontrib><creatorcontrib>CONNOR, DAVID THOMAS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MENETSKI, JOSEPH PETER</au><au>CONNOR, DAVID THOMAS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Benzenesulfonamide inhibitors of phosphodiesterase-IV for treating inflammation and TNF associated diseases</title><date>2002-03-01</date><risdate>2002</risdate><abstract>A method of inhibiting PDE-IV or TNF comprising contacting a cell with a compound of the formula shown. The pharmaceutical composition is suitable for the treatment of inflammatory or autoimmune diseases. Wherein; R1 and R2 represents C1-4alkyl or C3-10cycloalkyl; R3 and R4 independently represents C1-4alkyl, cycloalkyl, C2-4alkylenes having one double bond, (CH2)nCO(CH2)mCH3, (CH2)pCN, (CH2)pCO2Me, or taken together with nitrogen atom to which they are attached, form a 3-to 10-membered ring; n and m are 0-3; p is 1 to 3.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_NZ502965A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Benzenesulfonamide inhibitors of phosphodiesterase-IV for treating inflammation and TNF associated diseases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T08%3A01%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MENETSKI,%20JOSEPH%20PETER&rft.date=2002-03-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENZ502965A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true